Recursion Pharmaceuticals, Inc. (RXRX)
3.83
+0.29
(+8.19%)
USD |
NASDAQ |
Sep 18, 16:00
3.79
-0.04
(-1.04%)
After-Hours: 20:00
Recursion Pharmaceuticals 30-Day Average Daily Volume : 16.16M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 16.16M |
| September 17, 2026 | 15.18M |
| September 16, 2026 | 14.82M |
| September 15, 2026 | 15.04M |
| September 14, 2026 | 15.14M |
| September 11, 2026 | 15.08M |
| September 10, 2026 | 15.16M |
| September 09, 2026 | 15.40M |
| September 08, 2026 | 15.74M |
| September 04, 2026 | 15.97M |
| September 03, 2026 | 15.55M |
| September 02, 2026 | 15.72M |
| September 01, 2026 | 15.76M |
| August 31, 2026 | 15.92M |
| August 28, 2026 | 16.15M |
| August 27, 2026 | 16.44M |
| August 26, 2026 | 17.41M |
| August 25, 2026 | 17.63M |
| August 24, 2026 | 17.73M |
| August 21, 2026 | 18.05M |
| August 20, 2026 | 17.98M |
| August 19, 2026 | 18.00M |
| August 18, 2026 | 17.75M |
| August 17, 2026 | 18.17M |
| August 14, 2026 | 19.08M |
| Date | Value |
|---|---|
| August 13, 2026 | 19.82M |
| August 12, 2026 | 20.65M |
| August 11, 2026 | 21.08M |
| August 10, 2026 | 21.48M |
| August 07, 2026 | 22.43M |
| August 06, 2026 | 22.64M |
| August 05, 2026 | 22.66M |
| August 04, 2026 | 22.45M |
| August 03, 2026 | 22.22M |
| July 31, 2026 | 22.55M |
| July 30, 2026 | 22.78M |
| July 29, 2026 | 22.95M |
| July 28, 2026 | 22.86M |
| July 27, 2026 | 22.55M |
| July 24, 2026 | 22.67M |
| July 23, 2026 | 22.77M |
| July 22, 2026 | 22.74M |
| July 21, 2026 | 22.76M |
| July 20, 2026 | 23.16M |
| July 17, 2026 | 23.76M |
| July 16, 2026 | 23.73M |
| July 15, 2026 | 23.09M |
| July 14, 2026 | 23.48M |
| July 13, 2026 | 23.62M |
| July 10, 2026 | 23.63M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Twist Bioscience Corp. | 1.723M |
| Absci Corp. | 3.151M |
| Novavax, Inc. | 5.336M |
| Editas Medicine, Inc. | 2.980M |
| Amgen, Inc. | 2.718M |